<DOC>
	<DOC>NCT00616954</DOC>
	<brief_summary>This study is planned to evaluated whether ATG is needed in haploidentical stem cell transplantation</brief_summary>
	<brief_title>A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT</brief_title>
	<detailed_description />
	<mesh_term>Graft vs Host Disease</mesh_term>
	<criteria>1. Patient age 370 years old with a disease necessitating allogeneic SCT. 2. Patients must have a mismatched donor willing and capable of donating peripheral blood stem cells and/or bone marrow progenitor cells using conventional techniques, and lymphocytes if indicated (mismatched defined as 3/64/6 HLA matching). 3. Each patient / patient's guardian must sign written informed consent. 4. Patients must have an ECOG PS â‰¤ 2; Creatinine &lt;2.0 mg/dl; Ejection fraction &gt;40%; DLCO &gt;50% of predicted; Serum bilirubin &lt;3 gm/dl; elevated GPT or GOT &gt;3 x normal values. 1. Not fulfilling any of the inclusion criteria. 2. Active lifethreatening infection. 3. Overt untreated infection. 4. Known hypersensitivity to ATG. 5. HIV seropositivity, Hepatitis B or C antigen positivity with evidence of active hepatitis. 6. Pregnant or lactating women. 7. Donor contraindication (HIV seropositive confirmed by Western Blot Hepatitis B antigenemia; positive HCV antibodies with positive HCV PCR; evidence of bone marrow disease; unable to donate bone marrow or peripheral blood due to concurrent medical condition). 8. Inability to comply with study requirements.</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>mismatched</keyword>
	<keyword>Stem cell transplatation</keyword>
	<keyword>Bone marrow transplantation</keyword>
	<keyword>T cell depletion</keyword>
	<keyword>engraftment</keyword>
	<keyword>Patients undergoing allogeneic haplo-SCT</keyword>
</DOC>